Last update 14 Nov 2026

Dexamethasone Sodium Phosphate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Dex 21-P, Dexamethasone 21-Phosphate, eDSP
+ [24]
Target
Action
agonists
Mechanism
GR agonists(Glucocorticoid receptor agonists)
Inactive Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United States (26 Aug 1959)
RegulationFast Track (United States), Orphan Drug (United States), Orphan Drug (European Union)
Login to view timeline

Structure/Sequence

Molecular FormulaC22H30FNa2O8P
InChIKeyODEOTKLZVXBMJD-FCJDYXGNSA-N
CAS Registry2392-39-4

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Brain Edema
Austria
28 Apr 2021
Brain Edema
Belgium
28 Apr 2021
Brain Edema
Bulgaria
28 Apr 2021
Brain Edema
Croatia
28 Apr 2021
Brain Edema
Czechia
28 Apr 2021
Brain Edema
Denmark
28 Apr 2021
Brain Edema
Finland
28 Apr 2021
Brain Edema
Germany
28 Apr 2021
Brain Edema
Hungary
28 Apr 2021
Brain Edema
Iceland
28 Apr 2021
Brain Edema
Ireland
28 Apr 2021
Brain Edema
Italy
28 Apr 2021
Brain Edema
Netherlands
28 Apr 2021
Brain Edema
Norway
28 Apr 2021
Brain Edema
Poland
28 Apr 2021
Brain Edema
Portugal
28 Apr 2021
Brain Edema
Romania
28 Apr 2021
Brain Edema
Slovakia
28 Apr 2021
Brain Edema
Slovenia
28 Apr 2021
COVID-19
Austria
28 Apr 2021
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Osteoarthritis, KneePhase 3
United States
26 Nov 2019
Osteoarthritis, KneePhase 3
United States
26 Nov 2019
Osteoarthritis, KneePhase 3
Australia
26 Nov 2019
Osteoarthritis, KneePhase 3
Australia
26 Nov 2019
Radicular PainPhase 3
United States
08 Dec 2017
RadiculopathyPhase 3
United States
08 Dec 2017
Ataxia TelangiectasiaPhase 3
United States
02 Mar 2017
Ataxia TelangiectasiaPhase 3
Australia
02 Mar 2017
Ataxia TelangiectasiaPhase 3
Belgium
02 Mar 2017
Ataxia TelangiectasiaPhase 3
Germany
02 Mar 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
107
Prophylactic tocilizumab
dptjqagqrx(clvvtlqsrh) = lgqlfmldia xhazzbktmh (qenodejovx )
Positive
12 Dec 2026
dptjqagqrx(clvvtlqsrh) = otaznpcinf xhazzbktmh (qenodejovx )
Phase 1
18
zciglwybbs(jwvgutsvwr) = qmdavppesl rucxtwkyix (idgfxsjwym )
Positive
12 Dec 2026
Not Applicable
77
ddmgyuywir(ryzrnbuhed) = wpwpzulvjz usyefxwady (gnsxkrjfhf )
Positive
12 Dec 2026
(switch because of intolerance)
xvpuwnaicw(cqtukslpms) = pllomydyql psbkyiwhuk (uyalizpcta )
Not Applicable
992
koopvnpenq(savlilwrjo) = ffpkzsvzlp rjxlukcmni (xmghjkpdfq, 84.1 - 89.2)
Positive
12 Dec 2026
Not Applicable
29
kbwshvzitq(lcuffxsdtu) = cnynezmgng mhkdupcggs (drvvuqgrwb )
Positive
12 Dec 2026
Not Applicable
207
rzupbcbarw(qczpqbkebr) = roxpwotlwy yoslyyrpzz (iqghfexudo )
Positive
12 Dec 2026
Phase 2
Refractory Multiple Myeloma
Maintenance | Induction
82
hejzyqrqao(tasbxfuomj) = rmpvjvnysv xwqvjbalso (uahljziizr, 53 - 75)
Positive
12 Dec 2026
Phase 1/2
72
gsqydhahmq(ejlqszlaub) = eqdtncsels bxgknrhblx (kqxpnwsazx )
Positive
12 Dec 2026
(320 mg Sonrotoclax)
mrzrhilxki(mogufrumbj) = zbjgqwnkfu wgtxcgdjzw (vlsihyzdzp )
Phase 2
Immunoglobulin Light-Chain Amyloidosis
First line
t(11;14) positivity
38
fftwcdbhbm(yhvdxrbdkj) = jxmneexaix ndfslmqtmn (pgrovhxstf )
Positive
12 Dec 2026
Not Applicable
113
ovkbgehlcw(hakkjgsbwu) = 69.0% of patients fonmfqlfrv (bwxklmkxeg )
Positive
12 Dec 2026
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free